Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4

Sponsor Class

OTHER 5INDUSTRY 4

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Leiomyoma 3Myoma 2Menorrhagia 2Myofibroma 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Uterine Artery Embolization × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT03535610 2020-09-04

EMBOSOFT I

Scitech Produtos Medicos SA

Phase NA Completed
32 enrolled

Myofibroma

NCT02819609 2016-06-30

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

Quintiles, Inc.

Completed
12,234 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡